qPCR 仪器市场机会、成长动力、产业趋势分析与预测 2024 - 2032 年

2023 年，全球 qPCR 仪器市场价值 16 亿美元，预计 2024 年至 2032 年复合年增长率为 8.4%。全球各种疾病发病率的不断上升极大地增加了对 qPCR 等即时定量工具的需求。这些工具对于诊断和监测传染病、癌症和遗传性疾病至关重要，因为它们能够提供快速、准确的结果。都市化、人口老化和生活方式改变等因素导致非传染性疾病的增加，进一步推动了对 qPCR 技术的需求，特别是在感染率和慢性病高发生的地区。

对个人化医疗的日益关注也是推动 qPCR 仪器市场的关键因素。个人化医疗依赖精确的分子诊断，而 qPCR 可以实现详细的基因分析和即时监测。这种能力对于开发个人化治疗、识别基因突变和客製化治疗以满足患者的特定需求至关重要。随着个人化治疗需求的持续增长，qPCR 在药物开发和标靶治疗等领域的作用变得越来越突出，支持市场扩张。

就产品类型而言，qPCR 系统领域在 2023 年引领市场，创造 6.442 亿美元的收入。这些系统是即时 PCR 检测的支柱，为诊断、研究和药物开发中的定量分析提供关键平台。鑑于实验室、医院和诊所的购买和安装需要大量投资，qPCR 系统是市场中资本最密集的部分。然而，这些机器广泛用于各种应用，使其成为总收入的关键贡献者。

依应用，市场分为基因表现、基因分型、病原体检测、诊断等。 2023年，基因表现部分占最大份额，达26.6%。基因表现分析在分子生物学中发挥关键作用，帮助研究人员了解各种条件下的基因调控和表达，特别是在癌症研究、药物开发和疾病机制研究。这使得 qPCR 仪器对于此类应用至关重要，从而推动了持续的需求。

从地区来看，北美地区2023 年的销售额为6.21 亿美元，预计到2032 年将以8.1% 的复合年增长率增长。北美地区对先进诊断工具的需求。 qPCR 仪器以其准确性和速度而闻名，有助于快速检测病原体，使医疗保健提供者能够有效管理疾病爆发。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 疾病盛行率增加
    • 技术进步
    • 强调个人化医疗
    • 合约研究组织 (CRO) 的发展
  • 产业陷阱与挑战
    • 设备成本高
• 成长潜力分析
• 监管环境
• 技术景观
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032 年

• 主要趋势
• 定量PCR系统
• 试剂及耗材
• 软体

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 基因表现
• 基因分型
• 病原体检测
• 诊断
• 其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 诊断实验室
• 医院和诊所
• 製药和生物技术公司
• 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Abbott Laboratories
• Agilent Technologies, Inc.
• Azure Biosystems Inc.
• Bio Molecular Systems
• BIOMERIEUX SA
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Eppendorf
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• QIAGEN NV
• Quantabio
• Siemens Healthineers AG
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

The Global qPCR Instruments Market was valued at USD 1.6 billion in 2023 and is projected to grow at a CAGR of 8.4% from 2024 to 2032. Key drivers for this growth include the rising prevalence of diseases and an increasing focus on personalized medicine. The growing incidence of various diseases worldwide has significantly boosted the demand for real-time quantification tools like qPCR. These tools are crucial for diagnosing and monitoring infectious diseases, cancer, and genetic disorders due to their ability to provide rapid and accurate results. Factors such as urbanization, aging populations, and lifestyle changes have contributed to the rise in non-communicable diseases, further driving the need for qPCR technology, especially in areas with high rates of infections and chronic conditions.

The rising focus on personalized medicine is also a key factor propelling the qPCR instruments market. Personalized medicine relies on precise molecular diagnostics, and qPCR enables detailed genetic profiling and real-time monitoring. This capability is essential for developing individualized treatments, identifying genetic mutations, and tailoring therapies to meet the specific needs of patients. As the demand for personalized therapies continues to grow, qPCR's role in areas like drug development and targeted treatments is becoming more prominent, supporting market expansion.

In terms of product types, the qPCR systems segment led the market in 2023, generating USD 644.2 million. These systems are the backbone of real-time PCR testing, providing critical platforms for quantitative analysis in diagnostics, research, and drug development. qPCR systems are the most capital-intensive segment of the market, given the substantial investment required for their purchase and installation in labs, hospitals, and clinics. However, these machines are extensively utilized for various applications, making them a key contributor to overall revenue.

Based on application, the market is segmented into gene expression, genotyping, pathogen detection, diagnostics, and others. In 2023, the gene expression segment held the largest share, at 26.6%. Gene expression analysis plays a key role in molecular biology, helping researchers understand gene regulation and expression under various conditions, particularly in cancer research, drug development, and disease mechanism studies. This makes qPCR instruments vital for such applications, driving consistent demand.

Regionally, North America accounted for USD 621 million in 2023 and is expected to grow at a CAGR of 8.1% through 2032. The rising incidence of infectious diseases like HIV, influenza, and COVID-19 has significantly increased the demand for advanced diagnostic tools in the region. qPCR instruments, known for their accuracy and speed, are instrumental in detecting pathogens quickly, enabling healthcare providers to manage disease outbreaks effectively.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of diseases
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Emphasis on personalized medicine
    • 3.2.1.4 Growth of contract research organizations (CROs)
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of devices
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 qPCR systems
• 5.3 Reagents and consumables
• 5.4 Software

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Gene expression
• 6.3 Genotyping
• 6.4 Pathogen detection
• 6.5 Diagnostics
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Diagnostics laboratories
• 7.3 Hospitals & clinics
• 7.4 Pharma & biotech companies
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Agilent Technologies, Inc.
• 9.3 Azure Biosystems Inc.
• 9.4 Bio Molecular Systems
• 9.5 BIOMERIEUX SA
• 9.6 Bio-Rad Laboratories, Inc.
• 9.7 Danaher Corporation
• 9.8 Eppendorf
• 9.9 F. Hoffmann-La Roche Ltd.
• 9.10 Merck KGaA
• 9.11 QIAGEN N.V.
• 9.12 Quantabio
• 9.13 Siemens Healthineers AG
• 9.14 Takara Bio Inc.
• 9.15 Thermo Fisher Scientific Inc.